November 22, 2022
It’s Turkey Time
Before we get into the gist of our post today a huge shout out to the Wall Street Journal for finally getting it right when it comes to insulin pricing. For years now all we’ve been hearing is how Lilly Novo Nordisk and Sanofi have been, excuse the expression, sticking it to the insulin using community for consistently raising the “wholesale” cost of insulin. That they are somehow responsible for the “high” out of pocket cost of insulin. That they alone are responsible for what the consumer pays.
Check out this piece in today’s WSJ https://www.wsj . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.